Platelet Aggregation Devices Market Research Report by Product (Accessories, Consumables, Reagents, and Systems), by Application (Clinical and Research), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
The Global Platelet Aggregation Devices Market is expected to grow from USD 279.40 Million in 2019 to USD 685.18 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 16.12%.
Market Segmentation & Coverage: This research report categorizes the Platelet Aggregation Devices to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the Platelet Aggregation Devices Market studied across Accessories, Consumables, Reagents, and Systems.
Based on Application, the Platelet Aggregation Devices Market studied across Clinical and Research.
Based on End User, the Platelet Aggregation Devices Market studied across Blood Banks, Diagnostic Laboratories, Hospitals, and Research & Academic Institutes.
Based on Geography, the Platelet Aggregation Devices Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Company Usability Profiles: The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Platelet Aggregation Devices Market including Accriva Diagnostics, Aggredyne, Inc., F. Hoffman-La Roche Ltd, Haemonetics Corporation, Helena Laboratories Corporation, Sentinel Ch. S.P.A., Siemens AG, Sysmex Corporation, and Tem Group.
FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Platelet Aggregation Devices Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
Cumulative Impact of COVID-19: COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
The report provides insights on the following pointers: 1. Market Penetration: Provides comprehensive information on the market offered by the key players 2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as: 1. What is the market size and forecast of the Global Platelet Aggregation Devices Market? 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Platelet Aggregation Devices Market during the forecast period? 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Platelet Aggregation Devices Market? 4. What is the competitive strategic window for opportunities in the Global Platelet Aggregation Devices Market? 5. What are the technology trends and regulatory frameworks in the Global Platelet Aggregation Devices Market? 6. What are the modes and strategic moves considered suitable for entering the Global Platelet Aggregation Devices Market?
Our reports have been used by over 10K customers, including:
232 pages •
By Global Industry Analysts
• Jul 2020
Global Blood Collection and Processing Supplies Market to Reach $16 Billion by 2027 Amid the COVID-19 crisis, the global market for Blood Collection and Processing Supplies estimated at US$12.3 Billion in the year 2020, is projected to reach a revised size of US$16 Billion by 2027, growing at a CAGR of 3.9% over the analysis period...
Blood Bags Market Research Report by Type (Double, Quadruple, Single, and Triple), by End User (Blood Banks and Hospital) - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Blood Bags Market is expected to grow from USD 312.18 Million in 2019 to USD 437.87 Million by the end of 2025 at a Compound Annual...
Blood Purification Equipment - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Blood Purification Equipment pipeline products with comparative...
KEY FINDINGS The global blood market is estimated to grow with a CAGR of 4.16% across the forecast years of 2019 to 2028. Primary factors attributed to driving the market growth include, the increase in the worldwide demand for blood and blood-related products, the growing geriatric population, rise in blood and plasma...
188 pages •
By Global Industry Analysts
• Jul 2020
Global Plasma Fractionation Market to Reach $31.9 Billion by 2027 Amid the COVID-19 crisis, the global market for Plasma Fractionation estimated at US$22.1 Billion in the year 2020, is projected to reach a revised size of US$31.9 Billion by 2027, growing at a CAGR of 5.4% over the analysis period 2020-2027. Intravenous Immunoglobulins,...
221 pages •
By Global Industry Analysts
• Jul 2020
Global Leukapheresis Market to Reach $31.9 Million by 2027 Amid the COVID-19 crisis, the global market for Leukapheresis estimated at US$21.2 Million in the year 2020, is projected to reach a revised size of US$31.9 Million by 2027, growing at aCAGR of 6% over the period 2020-2027. Leukapheresis Devices, one of the segments analyzed...
Increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are driving the overall growth of the blood screening market The blood screening market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at...
Coagulation analyzers market to register a CAGR of 5.7% from 2020 to 2025 The global coagulation analyzers market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025. The growth of this market is majorly driven by factors such as the increasing prevalence of...
The Global Blood Market is poised to grow at a CAGR of around 5.7% by 2028. Some of the prominent trends that the market is witnessing include increasing occurrence of trauma cases and up-gradation in blood transfusion instruments. Based on end user the market is categorized into ambulatory surgical centers,...
Aplastic Anemia - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia – Pipeline Review, H1 2020, provides an overview of the Aplastic Anemia (Hematological Disorders) pipeline landscape. Aplastic anemia is a syndrome of bone marrow...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.